Press release
Free for publication on June 4, 2018 at 1.30pm (CEST +1)
Oulu, Finland, June 4, 2018 – Bittium exhibits its innovative products and solutions for neuroscience and cardiology at 8th Mismatch Negativity conference (MMN) 2018 on June 12-15 in Helsinki, Finland. At the event Bittium will showcase the recently European CE medical approved wireless Bittium BrainStatus™ EEG amplifier and electrode headband meant for real-time brain electrical activity monitoring and Bittium NeurOne™ monitoring solution for brain electrical activity measurement. Also presented are the Bittium Faros™ cardiac ECG signal measuring and monitoring devices.
Products and solutions exhibited at the conference are:
Bittium Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of the Bittium Faros device are used for event recording and mobile event monitoring. This technology enables earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster.
Further information:
Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 5466
Distribution:
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com